HIGHLIGHTS
- who: CalliSpheres beads and colleagues from the Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China have published the article: Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma, in the Journal: (JOURNAL) of 20/01/2022
- what: The authors aim to report the preliminary Patients and Methods Selection of Patients Patients who were clinically or histologically diagnosed with primary HCC, either matter unresectable or recurrent tumor, were recruited from the department between November 2019 and November 2021.
- how: The preliminary results showed that DEBTACE . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.